PITX2 and cancer: Paired-like homeodomain transcription factor 2 (PITX2) could act as an effective biomarker in human cancer diagnosis and prognosis progression of CRC; PITX2 enhanced resistance to 5-FU in CRC, upregulating the Wnt/β-catenin axis [203].